Celecoxib treatment does not alter recruitment and activation of osteoclasts in the initial phase of experimental tooth movement by Carvalho-Filho, E. P. et al.
  Universidade de São Paulo
 
2012
 
Celecoxib treatment does not alter recruitment
and activation of osteoclasts in the initial
phase of experimental tooth movement
 
 
EUROPEAN JOURNAL OF HISTOCHEMISTRY, PAVIA, v. 56, n. 4, supl. 1, Part 2, pp. 272-276,
MAY, 2012
http://www.producao.usp.br/handle/BDPI/41238
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Sem comunidade WoS
European Journal of Histochemistry 2012; volume 56:e43
[page 272] [European Journal of Histochemistry 2012; 56:e43]
Celecoxib treatment does not alter recruitment and activation of osteoclasts in theinitial phase of experimental tooth movement
E.P. Carvalho-Filho,1 A.C. Stabile,1E. Ervolino,2 M.B.S. Stuani,3M.M. Iyomasa,1 M.J.A. Rocha11Departamento de Morfologia,Estomatologia e Fisiologia, Faculdade deOdontologia de Ribeirão Preto,Universidade de São Paulo (USP),Ribeirão Preto;2Departamento de Ciências Básicas,Faculdade de Odontologia de Araçatuba,Universidade Estadual Paulista,Araçatuba;3Departamento de Pediatria eOrtodontia, Faculdade de Odontologia deRibeirão Preto, Universidade de SãoPaulo (USP), Ribeirão Preto, SP, Brazil
Abstract
In a previous study, we reported that the
short-term treatment with celecoxib, a non-
steroidal anti-inflammatory drug (NSAID)
attenuates the activation of brain structures
related to nociception and does not interfere
with orthodontic incisor separation in rats. The
conclusion was that celecoxib could possibly be
prescribed for pain in orthodontic patients.
However, we did not analyze the effects of this
drug in periodontium. The aim of this follow-up
study was to analyze effects of celecoxib treat-
ment on recruitment and activation of osteo-
clasts and alveolar bone resorption after insert-
ing an activated orthodontic appliance between
the incisors in our rat model. Twenty rats (400-
420 g) were pretreated through oral gavage with
celecoxib (50 mg/kg) or vehicle (carboxymethyl-
cellulose 0.4%). After 30 min, they received an
activated (30 g) orthodontic appliance, set not
to cause any palate disjunction.  In sham ani-
mals, the appliance was immediately removed
after introduction. All animals received ground
food and, every 12 h, celecoxib or vehicle. After
48 h, they were anesthetized and transcardia-
cally perfused through the aorta with 4%
formaldehyde. Subsequently, maxillae were
removed, post-fixed and processed for histomor-
phometry or immunohistochemical analyses. As
expected, incisor distalization induced an
inflammatory response with certain histological
changes, including an increase in the number
of active osteoclasts at the compression side in
group treated with vehicle (appliance:
32.2±2.49 vs sham: 4.8±1.79, P<0.05) and cele-
coxib (appliance: 31.0±1.45 vs sham: 4.6±1.82,
P<0.05). The treatment with celecoxib did not
modify substantially the histological alterations
and the number of active osteoclasts after acti-
vation of orthodontic appliance. Moreover, we
did not see any difference between the groups
with respect to percentage of bone resorption
area. Taken together with our previous results
we conclude that short-term treatment with
celecoxib can indeed be a therapeutic alterna-
tive for pain relieve during orthodontic proce-
dures.
Introduction
Orthodontic procedures may cause unpleas-
ant and even painful sensations, and these are
probably the most important factors for aver-
sion in patients and discontinuation of the
treatment. As a solution, orthodontists com-
monly use painkillers such as acetaminophen,
a non-steroidal anti-inflammatory drug
(NSAIDs), which is also the most frequently
prescribed analgesic to patients.1-4 The reason
for this being the drug of choice is that it does
not interfere with the tooth movement that is
intended and necessary in any such orthodon-
tic treatment. Acetaminophen only slightly
inhibits prostaglandin formation and does not
interfere in the bone resorption process. Its
analgesic action seems to be a central nervous
system effect associated with a minor local
anti-inflammatory effect.5,6 Notwithstanding,
like other non-selective NSAIDs, its use may
imply in adverse effects, with hepatic toxicity
and drug hypersensibility being the most com-
mon.7-10 Celecoxib is a possible candidate to be
prescribed to orthodontic patients when aceta-
minophen is counter-indicated. It acts selec-
tively on cyclooxygenase type 2, which results
in less adverse effects than those produced by
non-selective NSAIDs.8,9,11-15 Despite this
apparent advantage, the effects of celecoxib on
tooth movement are still unclear, especially
since experimental studies performed until
now report contradictory results.14,16-19
To address this question, we started to use a
rat model designed to reveal nociception path-
ways when applying an orthodontic force
between the incisors, and, in a previous study,
we could show that a short-term treatment (48
h) with celecoxib reduced neuronal activation
in brain structures related to nociception,
while not interfering with tooth movement.20
Given this, we concluded that in the short-term
application protocol, this drug worked as an
effective analgesic, without apparently com-
promising the kinetics of orthodontic move-
ment. An important aspect however, possible
effects on local bone resorption, was not ana-
lyzed. The aim of this follow-up study, thus,
was to analyze whether or not celecoxib treat-
ment affects the recruitment and activation of
osteoclasts and alveolar bone resorption in rats
submitted to orthodontic force.
Materials and MethodsAnimals
Twenty male Wistar rats, weighing 400 g
each, were kept in Plexiglas cages in a temper-
ature-controlled room (24±1°C) with a 12:12
hours L:D cycle. They had free access to water
and food. The experiments were reviewed and
approved by the Ethics Committee on the Use
of Experimental Animals of the University of
São Paulo, Campus of Ribeirão Preto (protocol
number: 06.1.1045.53.6). Experimental protocol
The animals were first anesthetized by an
intramuscular injection of ketamine (Vetaset,
100 mg/kg) and xylazine (Dopaser, 14 mg/kg).
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They then received an activated orthodontic
appliance set on the superior incisors, submit-
ting each tooth to a force of 30 g. This appli-
ance was either left in place for 48 h (appli-
ance group, n=10), or was immediately
removed after insertion (sham group, n=10).
Thirty minutes before, and 12, 24 and 36 h
after inserting the appliance, a 1 mL solution
containing celecoxib (CEL - Celebra, Pfizer,
New York, NY, USA) in a dose of 50 mg/kg, or
0.4% carboxymethylcellulose (CMC - vehicle)
were administered in subsets of both groups by
oral gavage. After 48 h, the animals were tran-
scardially perfused with 100 mL of phosphate-
buffered saline (PBS 0.01M, pH 7.4), followed
by 400 mL of 4% formaldehyde in 0.1 M phos-
phate buffer. The maxillae were removed post-
fixed by 24 h, and placed in an EDTA solution
(0.5M) containing TRIS 0,2M (pH7.4) for
approximately 28 days. Orthodontic appliance
A fixed orthodontic appliance designed to
induce tipping tooth movement and construct-
ed in our laboratory was used.21-23 It consists of
a torsion spring made of 0.016 inch stainless
steel wire that had each edge welded to two
stainless steel rings (adapted orthodontic
bands) of 0.004¥0.06 inches. These were cut
open in the middle so that they could be fixed
to the right and left incisors. After activating
the spring, tension was measured with a
dynamometer (Zeusan) and the appliance
inserted with the torsion spring adapted to the
rats’ mouth palate in a way that the orthodon-
tic band could be cemented to the incisor with
zinc oxyphosphate cement. Tissue preparation 
The segments of the maxilla containing the
root and crown of the incisors were submitted
to a demineralization procedure, followed by
dehydration in an ascending ethanol series
(50% for 30 min, 70% and 95% for 2 h each).
Subsequently, they were immersed and left
overnight in equal parts of alcohol and xylene,
diaphanized three times in xylene, with solu-
tions being changed every 2 h, and finally
embedded in paraffin. Coronal sections
through the maxilla including the upper inci-
sors region were cut at 6 µm thickness on a
microtome and further processed for hema-
toxylin-eosin staining or tartrate-resistant acid
phosphatase (TRAP) immunohistochemistry. Immunohistochemistry for tartrate-resistant acid phosphatase detection  
After deparaffinization with xylene, selected
sections were rehydrated in a descending
ethanol series, followed by washing with PBS
(0.1M, pH 7.4) and incubation for 1 h with PBS
containing 3% hydrogen peroxide to inactivate
endogenous peroxidase activity. After several
rinses in PBS, the sections were placed in 3%
bovine albumin serum for 1 h and then incu-
bated with the primary goat anti-TRAP (Santa
Cruz Biotechnology, Santa Cruz, CA, USA),
diluted 1:100 in PBS containing 0.3% Triton X-
100, for 24 h in a humid chamber at 4ºC. After
several washes in PBS, the sections were incu-
bated at room temperature with biotinylated
anti-goat IgG (Dako Laboratories, Carpinteria,
CA, USA) for 1 h. Subsequently, they were
washed in PBS and placed for 1 h in
Streptavidin-HRP complex (Universal Dako
Labeled -HR, Streptavidin-Biotin Kit®, Dako
Laboratories). Peroxidase activity was
revealed by 3, 3-diamino benzidine tetrachlo-
ride (DAB chromogen Kit, Dako Laboratories).
After rinses in PBS the sections were counter-
staining with Harris-Haematoxylin. Finally,
they were immersed in an ascending ethanol
series, xylene-cleared, and coverslipped with
Entellan. As negative control some sections
were submitted to the same procedure but
without the anti-TRAP serum. 
Original Paper
Figure 1. Photomicrographies of periodontium showing immunolabeling for the tartrate-
resistant acid phosphatase. Osteocyte are seen as weakly stained cells (white arrowheads)
and osteoclasts are large multinuclear cells with intense brown staining in the cytoplasm
(black arrowheads). Most of these cells showed intense  resorption activity once they were
adjusted to the resorption lacuna (rl) in the alveolar bone (ab), as visible in panel A.
Panels B and C are from the periodontium of animals that received the appliance, and D
and E are from the sham group (appliance removed). Periodontium of animals treated
with celecoxib (B and D) and with vehicle (C and E). ab, alveolar bone; d, dentine; pl,
periodontal ligament, rl, resorption lacuna.
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Analysis
For each selected section, five microscopic
fields of the distal periodontium were captured
by a light microscope connected to a digital
camera. The Image J, public domain software
(http://rsb.info.nih.gov/ij) was used to calculate
percentage bone resorption. Osteoclasts were
counted using this same software and in each
of five histological sections showing the alveo-
lar bone surface (compression side) adjacent to
the entire root. Cells were considered osteo-
clasts if they were multinucleated, TRAP posi-
tive, and located on or close to bone surfaces. All
data were analyzed by using the non-parametric
Kruskal-Wallis test followed by Dunn’s multiple
comparison test. All calculations were per-
formed with the software GraphPad Prism 4
(GraphPad Software Inc.) and the accepted sig-
nificance level was P<0.05.
Results
In both groups, treated with vehicle or cele-
coxib, it was possible to observe a histological
difference between the mesial (tension) and
distal (compression) area of the periodontal
ligament within 48 h after insertion and fixa-
tion of the orthodontic appliance. The tension
area showed disruption of collagen fibers and
the periodontal space was filled with an
extravascular fluid. In the compression area
we could see neutrophils that transmigrate
through the endothelium to the space among
several collagen fibers of the periodontal liga-
ment. The activation of orthodontic appliance
increased the number of active osteoclasts at
the compression side in group treated with
vehicle (appliance: 32.2±2.49 vs sham:
4.8±1.79, P<0.05) and celecoxib (appliance:
31.0±1.45 vs sham: 4.6±1.82, P<0.05). The
bone resorption percentage at the compres-
sion side only slightly increased but not signif-
icantly in group treated with vehicle (appli-
ance: 6.21±0.06% vs 4.18±0.05%, P>0.05) and
celecoxib sham (5.55±0.06% vs sham:
2.98±0.04%, P>0.05). Moreover, after the acti-
vation of orthodontic appliance we could not
see any difference between the groups with
respect to the active osteoclasts recruitment
(celecoxib: 31.0±1.45 vs vehicle: 32.2±2.49,
P>0.05) and percentage of bone resorption
area (celecoxib: 5.55±0.06% vs vehicle:
6.21±0.06%, P>0.05). Data are plotted in the
Table 1. Representative photomicrographics
are showed in the Figures 1 and 2. 
Discussion
In our rat model, a short-term celecoxib
treatment did not alter the recruitment and
activation o osteoclasts and bone resorption
area at the compression side after the applica-
tion of orthodontic force. Hence, this treat-
ment does not affect the tooth movement as
already reported by our previous work.20 Our
results are in accordance with those of previ-
ous investigators that also used experimental
tooth movement to study the effect of coxib
therapies.14,16 Though in distinction to these,
drug treatment in our study was applied via
oral 30 min before and then four times every
12 h after the application of the orthodontic
force. This treatment schedule was designed to
mimic the typical clinical procedure for cele-
coxib prescription, following recommenda-
tions in orthodontia on the preemptive or pre-
operative administration of analgesics to
decrease postoperative pain.24-28
Mechanical forces applied to a tooth affect
its relationship with the alveolar bone, creat-
ing  pressure and tension zones, and eventual-
ly elicits a local inflammatory reaction which
allows the tooth to migrate inside the alveolar
bone.21,22,29-35 In fact, we could see a local
inflammatory reaction in the compression
periodontal ligament following insertion of the
orthodontic appliance. This included local
alterations in vascularity, as well as cellular
and extracellular matrix reorganization and a
periodontal space narrowing. Even though the
molecular alterations occuring in the peri-
odontal ligament, especially in the initial phas-
es following mechanical stress, are not yet
clear, it is established that neurotransmitters,
cytokines, growth factors, colony-stimulating
factors, and metabolites of arachidonic acid
are involved.31 We herein chose to analyze the
periodontium 48 h after the application of the
orthodontic appliance because this is the peri-
od when pain is frequently reported in clinical
Original Paper
Figure 2. Photomicrographs of the periodontium (H&E stain) of sham animals (A and C)
or   those that received the appliance (B and D). Respective vehicle-treated animals are
shown in A and B, and those receiving celecoxib in C and D. ab, alveolar bone; d, den-
tine; pl, periodontal ligament. 
Table 1. Bone resorption and osteoclast number in the periodontium of sham animals
(appliance removed) and those that received the appliance for 48 h and were treated with
either vehicle (carboxymethyl cellulose) or celecoxib.
Sham Appliance
Vehicle Celecoxib Vehicle Celecoxib
Bone resorption (%) 4.18±0.05 2.98±0.04 6.21±0.06 5.55±0.06
Osteoclast number 4.8±1.79 4.6±1.82 32.2±2.49* 31.0±1.45*
Values represent mean + SEM (for 5 animals/group); *P<0.05 in relation to sham.
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routine.3,36-40 Furthermore, this period repre-
sents the initial phase of dental movement,
when pressure stimulates periodontal recep-
tors and elicits inflammatory reactions accom-
panied by the production of hyperalgesic sub-
stances.41 Prostaglandins, which are among
such hyperalgesic compounds, are thought to
affect bone remodelation, while themselves
being affected by NSAIDs.34,42 Bone remodel-
ing, thus, requires the inflammatory process to
cause the desired tooth movement in an ortho-
dontic treatment, but could in turn be affected
by NSAID treatment.
Osteoclasts play an important role in the
remodeling bone process.43 It was reported that
these cells migrate from the medullar cavity to
the periodontal ligament approximately within
48 h after installation of an orthodontic appa-
ratus,44 which is in accordance with the pres-
ent study. The osteoclast is a monocyte-derived
cell whose development is dependent on fac-
tors produced by activated osteoblasts in
response to inflammatory or immunological
signaling.45,46 The cytoplasm membrane of an
inactive osteoclast is straight and faces to the
bone, but without adhering to its surface. Such
cells differentiate into active osteoclasts when
stimulated by certain factors and then begin to
express a proton pump in the folded edge of
their cell membrane facing the bone surface
gap.47 The osteoclasts can be identified
through histochemistry or immunohistochem-
istry methods by detection of the tartrate-
resistant acid phosphatase (TRAP), an iso-
enzyme of the group of acid phosphatases,
which is highly expressed by activated osteo-
clasts.46 Using immunohistochemistry we
observed an increase in the number of active
osteoclasts in the distal periodontal ligament
following the orthodontic force application,
there was no significant increase in the bone
resorption area. This could be explained by the
fact that in our analysis we targeted an early
period of events that preceded the actual bone
resorption process. Altogether, this and previ-
ous work showed that celexocib did not affect
the recruitment and activation of osteoclasts
and incisor separation but attenuated the acti-
vation of brain structures related to nocicep-
tion following experimental tooth movement.
Consi dering that orthodontic patients usually
will not use NSAIDs for a prolonged period of
time, because pain rarely lasts more than 48 h,
we believe that celecoxib may be a safe alter-
native medication for orthodontic patients. 
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